These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9362312)

  • 1. Renal and vascular effects of C-type and atrial natriuretic peptides in humans.
    Pham I; Sediame S; Maistre G; Roudot-Thoraval F; Chabrier PE; Carayon A; Adnot S
    Am J Physiol; 1997 Oct; 273(4):R1457-64. PubMed ID: 9362312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H; Pedersen EB
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
    Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
    Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of atrial natriuretic peptide during dopamine infusion.
    Hirata Y; Fukui K; Hayakawa H; Suzuki E; Sugimoto T; Kimura K; Matsuoka H; Sugimoto T
    Am J Hypertens; 1990 Nov; 3(11):866-9. PubMed ID: 2175625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
    Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
    Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
    Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation potentiates the natriuretic and diuretic effects of atrial natriuretic peptide in anaesthetized rabbits.
    Christy IJ; Denton KM; Anderson WP
    Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):41-8. PubMed ID: 8156651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type natriuretic peptide in chronic renal failure and its action in humans.
    Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K
    Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of atrial natriuretic peptide on renal function and the renin-aldosterone system in anesthetized rabbits.
    Nushiro N; Abe K; Seino M; Itoh S; Yoshinaga K
    Tohoku J Exp Med; 1987 Jul; 152(3):301-10. PubMed ID: 2958960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type natriuretic peptide: a selective cardiovascular peptide.
    Clavell AL; Stingo AJ; Wei CM; Heublein DM; Burnett JC
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R290-5. PubMed ID: 8383462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of atrial natriuretic peptide infusion in young and adult rats.
    Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM
    Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.